Thiamine Mononitrate USP

Start with the standard and the exact material

A search for thiamine mononitrate USP should lead to a specification review, not simply a supplier label. Vitamin B1 is the vitamin name; thiamine mononitrate identifies the chemical form offered here. The published B1 documentation references BP2022, USP43, EP10.0 and FCC12. Those edition references matter when a buyer compares an existing raw-material specification with the supplier package. They do not establish that every subsequent edition or every application requirement has been evaluated. Ask QA to identify the applicable monograph, edition and acceptance criteria before treating the material as approved for a production formula.

Read the assay with its source

The published manufacturer assay for batch Y02202501042 is 99.5%; the independent Sigma assay is 99.3%. These are separate reported results and should remain separately attributed in a qualification record. A procurement summary should not average the two values or present one as a substitute for the other. Request the complete reports to review the analytical method, result basis, sample identity and reporting details. An assay number is useful evidence of the tested attribute, but it is not a complete compendial assessment. QA still needs to review the other applicable tests and the supporting documentation.

Review more than a headline purity number

The existing B1 analytical summary also lists loss on drying at 0.15%, residue on ignition at 0.12%, related compounds at 0.30%, chloride and sulfate below 0.06%, and pH at 7.27. These summary values are not new acceptance limits and should not be read as a universal specification for all thiamine material. Compare each reported parameter with its corresponding source document, method and required limit. Where the summary does not identify the method or calculation basis, obtain the full technical package rather than making an assumption. A signed QA assessment should distinguish reported results from the buyer's own acceptance criteria.

Link compendial review to the physical batch

The documented B1 position is 1,500 kg from Huazhong Pharmaceutical Co., Ltd., batch Y02202501042. Manufacture is recorded as January 26, 2025, and expiry as January 25, 2028. The inventory is warehoused in South Carolina in palletized 20 kg fiber drums. These identifiers let a buyer connect the specification review to a defined batch rather than to a generic product brochure. Before purchase, confirm remaining availability, the quantity offered, the shipment's batch references and any required storage or handling instructions. Warehouse location describes the current supply position; it is not a claim of U.S. manufacture.

Build a useful qualification request

Include your company, intended application, required quantity, destination and required-by date when requesting the B1 technical package. Tell Duke which compendial edition your QA team uses and which tests require clarification. If your internal specification differs from the published summary, provide the relevant requirement for review rather than assuming equivalence. Qualified buyers can request full-resolution manufacturer COA and independent QC documentation through the existing inquiry process; an NDA may be required. Once QA and regulatory review are complete, request commercial terms against the actual quantity and delivery needs. Document release, a sample request and a quote are distinct steps, not evidence of automatic supplier approval.

Resolve edition differences before issuing the specification

A buyer may maintain an internal raw-material specification that cites a different edition from the supplier's public reference. In that situation, make a documented comparison of the relevant requirements rather than treating the standard names as automatically equivalent. List the tests that match, the tests that require explanation and any acceptance limits your procedure adds. Send those questions with the technical-package request. Procurement can help collect the evidence, but the technical decision belongs with the authorized reviewers. If the source package does not answer a particular question, keep that item open until clarification or the buyer's required evaluation is complete.

The purchasing specification should also identify the form of B1 being ordered. A general requirement for thiamine is not sufficient to establish that thiamine mononitrate matches an approved ingredient record. Check the naming used in your formulation, receiving system and supplier documentation. Once the material is qualified, retain the batch-specific COA and independent report alongside the approved specification so that receiving does not rely on a generic website description. If a future order uses a different batch, reassess which parts of the review carry forward and which require fresh evidence. This page addresses the documented batch offered here, not an ongoing guarantee about every future B1 supply.